In dogs diagnosed with osteoarthritis, how safe and effective is long-term treatment with bedinvetmab in providing analgesia?

Abstract

The original article was published in Veterinary Evidence Vol 8, Issue 1 (2023): https://doi.org/10.18849/ve.v8i1.598 To aid interpretation, certain statements in the Knowledge Summary have been clarified. Refer to the full text and PDF for these amendments and corrections.

Keywords

• canine
• osteoarthritis
• bedinvetmab
• monoclonal antibody
• canine nerve growth factor
• analgesia
• chronic osteoarthritis associated pain
• safety
• effectiveness